3CON Pharma Medical GmbH

ATBRA.597020-000

active

Rechtsform

GmbH

Gegründet

17. Januar 2023

Land

Österreich

Firmensitz

Oberndorf 128c

6341 Ebbs

Tyrol

Österreich

Kontakt

E-Mail

office@3conpharma.com

Geschäftsführung

Alexander Auer

Managing Director

Seit 26. Januar 2023

Finanzen

Jahr	Umsatz	Gewinn	Bilanzsumme	Eigenkapitalquote
2024	~450.000 €	~-15.435 €	16.170 €	-262.9%
2023	~550.000 €	~-62.067 €	56.414 €	-48.0%

Branche

NACE 21.20Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen ErzeugnissenISIC 2100Manufacture of pharmaceuticals, medicinal chemical and botanical productsNAICS 325199Basic Chemical ManufacturingNAICS 325411Pharmaceutical and Medicine ManufacturingNAICS 325412Pharmaceutical and Medicine ManufacturingNAICS 325413Pharmaceutical and Medicine ManufacturingNAICS 325414Pharmaceutical and Medicine ManufacturingNAICS 339113Medical Equipment and Supplies ManufacturingUKSIC 21.20Manufacture of pharmaceutical preparationsNACE2025 21.20Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen

Rohdaten

{
  "id": "8022f5ae-3dd0-480a-a7c5-69d2d4bc4531",
  "euId": "ATBRA.597020-000",
  "name": "3CON Pharma Medical GmbH",
  "legalForm": "GmbH",
  "status": "active",
  "foundationDate": "2023-01-17T00:00:00",
  "vatId": null,
  "hq": {
    "line2": null,
    "street": "Oberndorf 128c",
    "city": "Ebbs",
    "zipCode": "6341",
    "state": "Tyrol",
    "country": "AT",
    "latitude": 47.615132,
    "longitude": 12.2116596
  },
  "contactData": {
    "emails": [
      "office@3conpharma.com"
    ],
    "phones": [],
    "websites": [],
    "faxes": []
  },
  "managers": [
    {
      "name": "Alexander Auer",
      "position": "Managing Director",
      "startDate": "2023-01-26T00:00:00",
      "endDate": null
    }
  ],
  "industry": {
    "isic": [
      "2100"
    ],
    "nace": [
      "21.20"
    ],
    "nace2025": [
      "21.20"
    ],
    "naics": [
      "325199",
      "325411",
      "325412",
      "325413",
      "325414",
      "339113"
    ],
    "uksic": [
      "21.20"
    ],
    "wz": []
  },
  "financials": [
    {
      "year": 2023,
      "currency": "EUR",
      "capital": 35000,
      "capitalIsEstimate": false,
      "balanceTotal": 56414.24,
      "balanceTotalIsEstimate": false,
      "earnings": -62067.05,
      "earningsIsEstimate": true,
      "earningsCagr": 0,
      "earningsCagrIsEstimate": false,
      "revenue": 550000,
      "revenueIsEstimate": true,
      "revenueCagr": 0,
      "revenueCagrIsEstimate": false,
      "returnOnSales": -11.284918181818181,
      "returnOnSalesIsEstimate": true,
      "equity": -27067.05,
      "equityIsEstimate": false,
      "equityRatio": -47.97910952979248,
      "equityRatioIsEstimate": false,
      "cash": 48482.01,
      "cashIsEstimate": false,
      "receivables": 5790.43,
      "receivablesIsEstimate": false,
      "liabilities": 82981.29,
      "liabilitiesIsEstimate": false
    },
    {
      "year": 2024,
      "currency": "EUR",
      "capital": 35000,
      "capitalIsEstimate": false,
      "balanceTotal": 16169.62,
      "balanceTotalIsEstimate": false,
      "earnings": -15435.440000000002,
      "earningsIsEstimate": true,
      "earningsCagr": 0,
      "earningsCagrIsEstimate": false,
      "revenue": 450000,
      "revenueIsEstimate": true,
      "revenueCagr": -18.181818181818176,
      "revenueCagrIsEstimate": true,
      "returnOnSales": -3.430097777777778,
      "returnOnSalesIsEstimate": true,
      "equity": -42502.49,
      "equityIsEstimate": false,
      "equityRatio": -262.85398172622484,
      "equityRatioIsEstimate": false,
      "cash": 10616.59,
      "cashIsEstimate": false,
      "receivables": 5553.03,
      "receivablesIsEstimate": false,
      "liabilities": 57672.11,
      "liabilitiesIsEstimate": false
    }
  ]
}